001     169666
005     20240312141419.0
024 7 _ |a 10.1172/JCI136778
|2 doi
024 7 _ |a pmid:34196299
|2 pmid
024 7 _ |a 0021-9738
|2 ISSN
024 7 _ |a 1558-8238
|2 ISSN
024 7 _ |a altmetric:108567364
|2 altmetric
037 _ _ |a DKFZ-2021-01488
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Sicklinger, Florian
|b 0
245 _ _ |a Basophils balance healing after myocardial infarction via IL-4/IL-13.
260 _ _ |a Ann Arbor, Mich.
|c 2021
|b ASCJ
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1710249234_32557
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The inflammatory response after myocardial infarction (MI) is a precisely regulated process that greatly affects subsequent remodeling. Here, we show that basophil granulocytes infiltrated infarcted murine hearts, with a peak occurring between days 3 and 7. Antibody-mediated and genetic depletion of basophils deteriorated cardiac function and resulted in enhanced scar thinning after MI. Mechanistically, we found that basophil depletion was associated with a shift from reparative Ly6Clo macrophages toward increased numbers of inflammatory Ly6Chi monocytes in the infarcted myocardium. Restoration of basophils in basophil-deficient mice by adoptive transfer reversed this proinflammatory phenotype. Cellular alterations in the absence of basophils were accompanied by lower cardiac levels of IL-4 and IL-13, two major cytokines secreted by basophils. Mice with basophil-specific IL-4/IL-13 deficiency exhibited a similarly altered myeloid response with an increased fraction of Ly6Chi monocytes and aggravated cardiac function after MI. In contrast, IL-4 induction in basophils via administration of the glycoprotein IPSE/α-1 led to improved post-MI healing. These results in mice were corroborated by the finding that initially low counts of blood basophils in patients with acute MI were associated with a worse cardiac outcome after 1 year, characterized by a larger scar size. In conclusion, we show that basophils promoted tissue repair after MI by increasing cardiac IL-4 and IL-13 levels.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
650 _ 7 |a Cardiology
|2 Other
650 _ 7 |a Cardiovascular disease
|2 Other
650 _ 7 |a Heart failure
|2 Other
650 _ 7 |a Innate immunity
|2 Other
700 1 _ |a Meyer, Ingmar Sören
|b 1
700 1 _ |a Li, Xue
|b 2
700 1 _ |a Radtke, Daniel
|b 3
700 1 _ |a Dicks, Severin
|b 4
700 1 _ |a Kornadt, Moritz P
|b 5
700 1 _ |a Mertens, Christina
|b 6
700 1 _ |a Meier, Julia K
|b 7
700 1 _ |a Lavine, Kory J
|b 8
700 1 _ |a Zhang, Yunhang
|b 9
700 1 _ |a Kuhn, Tim Christian
|b 10
700 1 _ |a Terzer, Tobias
|0 P:(DE-He78)9c4af0f5ceb3a2072b3736274eadf20e
|b 11
700 1 _ |a Patel, Jyoti
|b 12
700 1 _ |a Börries, Melanie
|0 P:(DE-He78)49bdb7cb4094fbf35c269ffa3e93ebc6
|b 13
|u dkfz
700 1 _ |a Schramm, Gabriele
|b 14
700 1 _ |a Frey, Norbert
|b 15
700 1 _ |a Katus, Hugo A
|b 16
700 1 _ |a Voehringer, David
|b 17
700 1 _ |a Leuschner, Florian
|b 18
773 _ _ |a 10.1172/JCI136778
|g Vol. 131, no. 13, p. e136778
|0 PERI:(DE-600)2018375-6
|n 13
|p e136778
|t The journal of clinical investigation
|v 131
|y 2021
|x 1558-8238
909 C O |p VDB
|o oai:inrepo02.dkfz.de:169666
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)9c4af0f5ceb3a2072b3736274eadf20e
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)49bdb7cb4094fbf35c269ffa3e93ebc6
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
913 0 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Cancer risk factors and prevention
|x 0
914 1 _ |y 2021
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J CLIN INVEST : 2019
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2021-01-27
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-01-27
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2021-01-27
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b J CLIN INVEST : 2019
|d 2021-01-27
920 1 _ |0 I:(DE-He78)C060-20160331
|k C060
|l C060 Biostatistik
|x 0
920 1 _ |0 I:(DE-He78)FR01-20160331
|k FR01
|l DKTK Koordinierungsstelle Freiburg
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C060-20160331
980 _ _ |a I:(DE-He78)FR01-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21